scispace - formally typeset
J

Jonathan Douxfils

Researcher at Université de Namur

Publications -  199
Citations -  5436

Jonathan Douxfils is an academic researcher from Université de Namur. The author has contributed to research in topics: Medicine & Dabigatran. The author has an hindex of 31, co-authored 158 publications receiving 3855 citations. Previous affiliations of Jonathan Douxfils include French Institute of Health and Medical Research & University of California, Davis.

Papers
More filters
Journal ArticleDOI

Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate.

TL;DR: APTT could be used for the monitoring of dabigatran and as screening test for the risk of overdose and HTI should be considered as the gold-standard because of its higher sensitivity, good reproducibility, excellent linear correlation at all doses, its simplicity of use, and possibilities of automation.
Journal ArticleDOI

Erratum to “Preventive Strategies against Bleeding due to Nonvitamin K Antagonist Oral Anticoagulants”

TL;DR: In the paper titled “preventive strategies against bleeding due to nonvitamin K antagonist oral anticoagulants,” the authors' given first and last names were inverted.
Journal ArticleDOI

International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants.

TL;DR: This inaugural coagulation ICSH document was developed by an ad hoc committee, comprised of international clinical and laboratory direct acting oral anticoagulant (DOAC) experts, and provided recommendations for the proper validation or verification of performance of laboratory assays prior to implementation for clinical use and external quality assurance.
Journal ArticleDOI

Assessment of the impact of rivaroxaban on coagulation assays: Laboratory recommendations for the monitoring of rivaroxaban and review of the literature

TL;DR: PT may be used as screening test to assess the risk of bleedings and a more specific and sensitive assay such as Biophen DiXaI using calibrators should be used to confirm the concentration of rivaroxaban.